𝔖 Bobbio Scriptorium
✦   LIBER   ✦

664 - Phase II study of gemcltablne in patients with metastatic breast cancer

✍ Scribed by M. Blackstein; C.L. Vogel; R. Ambinder; J. Cowan; P. Pearce; J. Iglesias


Book ID
117664911
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
266 KB
Volume
33
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase II study of ionidamine in patients
✍ H. Ian Robins; Donna S. Neuberg; Al B. Benson; Kishan J. Pandya; Douglass C. Tor πŸ“‚ Article πŸ“… 1990 πŸ› Springer US 🌐 English βš– 193 KB

The Eastern Cooperative Oncology Group conducted a phase II study of lonidamine in patients with metastatic breast cancer. The drug was given orally to a maximum daily dose of 340 mg/m 2. Forty-two patients were entered on study. One partial response was observed; there were no life-threatening toxi